A detailed history of Dimensional Fund Advisors LP transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 221,162 shares of MORF stock, worth $7.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
221,162
Previous 235,226 5.98%
Holding current value
$7.53 Million
Previous $6.79 Million 14.59%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$26.64 - $40.31 $374,664 - $566,919
-14,064 Reduced 5.98%
221,162 $7.78 Million
Q4 2023

Feb 07, 2024

SELL
$19.95 - $31.0 $5.88 Million - $9.13 Million
-294,587 Reduced 55.6%
235,226 $6.79 Million
Q3 2023

Nov 09, 2023

BUY
$21.33 - $59.42 $814,358 - $2.27 Million
38,179 Added 7.77%
529,813 $12.1 Million
Q2 2023

Aug 09, 2023

BUY
$34.33 - $62.11 $6.34 Million - $11.5 Million
184,666 Added 60.16%
491,634 $28.2 Million
Q1 2023

May 12, 2023

BUY
$26.01 - $48.69 $1.45 Million - $2.71 Million
55,726 Added 22.18%
306,968 $11.6 Million
Q4 2022

Feb 09, 2023

BUY
$24.14 - $30.37 $1.45 Million - $1.82 Million
60,081 Added 31.43%
251,242 $6.72 Million
Q3 2022

Nov 10, 2022

SELL
$22.23 - $33.37 $3.44 Million - $5.17 Million
-154,816 Reduced 44.75%
191,161 $5.41 Million
Q2 2022

Aug 12, 2022

SELL
$19.74 - $43.01 $388,443 - $846,350
-19,678 Reduced 5.38%
345,977 $7.51 Million
Q1 2022

May 13, 2022

BUY
$36.25 - $52.02 $2.1 Million - $3.02 Million
58,015 Added 18.86%
365,655 $14.7 Million
Q4 2021

Feb 09, 2022

BUY
$43.27 - $65.72 $3.08 Million - $4.68 Million
71,138 Added 30.08%
307,640 $14.6 Million
Q3 2021

Nov 12, 2021

BUY
$53.61 - $67.5 $6.22 Million - $7.83 Million
116,020 Added 96.3%
236,502 $13.4 Million
Q2 2021

Aug 12, 2021

BUY
$45.13 - $64.99 $5.44 Million - $7.83 Million
120,482 New
120,482 $6.92 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.31B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.